← Leaderboards
Kevin G. Peters
University Of California, San Diego
$754,356
Attributed
$1,398,507
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2015–19$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$1,398,507 · 3
By mechanism
R01$966,226 · 1
R43$225,000 · 1
R44$207,281 · 1
Top collaborators
- Randall S Johnson1 shared
- Victor Nizet1 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Sunil J Advani$4,585,067
- Li-Fan Lu$8,880,145
- Napoleone Ferrara$2,482,045
- Victor Nizet$31,303,620
- Robert N Weinreb$22,653,673
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsAgonistPre-ClinicalLeadPathway InteractionsMouse ModelDrug KineticsLungIn VivoLigandsGenerationsEndothelial CellsInhibitor/AntagonistCellsBiologicalBaseAngiopoietin-2Cell DeathDevelopment PlansBlood VesselsApoptosisFda ApprovedClinical TrialsIn Vitro
Grant awards (3)
Advancing ARP-1536, an Anti-VE-PTP Antibody, as an Adjunctive Therapy for the Treatment of Sight-Threatening Retinopathies$207,281
R44 · FY2019 · EY · contact PI
Boosting Innate Immunity Through HIF to Treat Antibiotic-Resistant Infections$966,226
R01 · FY2015 · AI
Small Molecule Inhibitors of VE-PTP to Mitigate Damage by Radiation Therapy$225,000
R43 · FY2015 · DE · contact PI